Skip to main content
. 2021 Jul 17;22(14):7652. doi: 10.3390/ijms22147652
(T-PLL) T-cell prolymphocytic leukemia
AKT serine/threonine-specific protein kinase
ALL acute lymphoblastic leukemia
AML acute myeloid leukemia
BiTE bispecific T-cell engaging
B-NHL B-cell non-Hodgkin lymphoma
CAR chimeric antigen receptor
CLL chronic lymphocytic leukemia
COVID 19 coronavirus disease 2019
CRES CAR T-cell-related encephalopathy syndrome
CRP C-reactive protein
CRS cytokine release syndrome
CSF colony-stimulating factor
DLBCL diffuse Large B-cell Lymphoma
FDA Food and Drug Administration
GCSF granulocyte colony-stimulating factor
HGF hepatocyte growth factor
HLH haemophagocytic lymphohistiocytosis
HSCT hematopoietic stem cell transplantation
ICU intensive care unit
IFN interferon
IL interleukin
IL6R IL6 Receptor
IP-10 interferon–inducible protein 10
JAK Janus associated kinase
mAbs monoclonal antibodies
MAPK mitogen-activated protein kinase
MAS macrophage activation syndrome
MCP monocyte chemoattractant protein
MIP macrophage inflammatory protein 1α
MSC mesenchymal stem cells
NHL non-Hodgkin lymphoma
NK natural killer
PT prothrombin time
PTT partial thromboplastin time
SARS-CoV-2 severe acute respiratory syndrome coronavirus 2
sIL6R soluble IL6 receptor
SS Sézary syndrome
STAT signal transducer and activator of transcription
TGF transforming growth factors
TNF tumor necrosis factors